Physician profile
Jacquelynn White
NPI 1194739896
$908.11
in general payments reported to CMS, 2019-2025
12 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Oncology (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $263).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.80 · 2022: $143 · 2023: $202 · 2024: $297 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $353.09 | 2022-2025 | Jakafi, Jakafi |
| Janssen Biotech, INC. | $199.12 | 2022-2024 | Tecvayli, Darzalex, Carvykti |
| Novartis Pharmaceuticals Corporation | $100.17 | 2022-2025 | |
| Kite Pharma, INC. | $53.14 | 2021-2023 | |
| Abbvie INC. | $45.86 | 2023-2025 | |
| Pfizer INC. | $34.91 | 2025 | |
| Jazz Pharmaceuticals INC. | $31.00 | 2024 | |
| Astellas Pharma US INC | $22.16 | 2025 | Cresemba |
| Alexion Pharmaceuticals, INC. | $21.84 | 2024 | Ultomiris |
| Genzyme Corporation | $16.57 | 2024 | |
| Eisai INC. | $15.71 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $14.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelynn White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.